Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elizabeth Iannotti Buchbinder, M.D.

Concepts (243)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma53202457404.940 Why?
Skin Neoplasms16202458911.420 Why?
Immunotherapy13202447281.040 Why?
Uveal Neoplasms220243440.900 Why?
Interleukin-24202418940.880 Why?
Proto-Oncogene Proteins B-raf6202320720.750 Why?
Mucous Membrane320236600.720 Why?
Cancer Vaccines4202310440.700 Why?
Antineoplastic Agents102020137080.600 Why?
Protein Kinase Inhibitors7202457090.580 Why?
Antibodies, Monoclonal10202092630.570 Why?
Pyrroles3202411270.560 Why?
Music Therapy320231110.550 Why?
Molecular Targeted Therapy5201928340.440 Why?
Mitogen-Activated Protein Kinase Kinases320236390.390 Why?
T-Lymphocytes, Cytotoxic2201517970.380 Why?
Neoplasms102023223860.360 Why?
Indoles2201618340.360 Why?
Disabled Children120132510.350 Why?
Mutation102023302430.340 Why?
Drug Resistance, Neoplasm3202453420.340 Why?
Interferon-alpha120149090.340 Why?
Colitis3202212440.300 Why?
Antineoplastic Combined Chemotherapy Protocols112024118430.290 Why?
Drug Therapy, Combination4202463200.290 Why?
Aminopyridines220245780.280 Why?
Humans7420247684510.260 Why?
Neoplasms, Second Primary2202210620.230 Why?
Ploidies120242870.230 Why?
Cytokines2202174490.220 Why?
Carcinoma, Renal Cell1201931970.220 Why?
Combined Modality Therapy6202385590.220 Why?
Immunologic Memory2202113750.210 Why?
Neoplasm Metastasis7202449310.210 Why?
Mitogen-Activated Protein Kinases2201712460.200 Why?
Kidney Neoplasms1201942980.200 Why?
Middle Aged2920242234180.190 Why?
Enterocolitis120221060.190 Why?
Antigens, Neoplasm2202120030.180 Why?
Gastritis120222000.180 Why?
Angiopoietin-2120211730.180 Why?
Splenic Neoplasms12021970.180 Why?
Receptors, Vascular Endothelial Growth Factor120246650.180 Why?
Caregivers1201323020.170 Why?
Stress, Psychological3202345380.170 Why?
Male3620243647810.170 Why?
Music120232470.170 Why?
Lung Neoplasms32023135890.170 Why?
Aged2420241715200.170 Why?
Medical Oncology2202323470.170 Why?
Lymphoma, B-Cell, Marginal Zone120211800.160 Why?
Colitis, Microscopic12020710.160 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120238950.160 Why?
Aged, 80 and over142024596800.160 Why?
Female3420243969430.160 Why?
Kaplan-Meier Estimate3201965370.160 Why?
Parents1201335960.160 Why?
MAP Kinase Kinase Kinases220172520.150 Why?
Brain Neoplasms4202191820.140 Why?
Adult2320242235420.140 Why?
Carcinoma, Non-Small-Cell Lung1201654260.140 Why?
Radiosurgery2202013540.140 Why?
Retrospective Studies182024818340.130 Why?
Antibodies, Blocking120172500.130 Why?
Mitogen-Activated Protein Kinase 3120174740.130 Why?
Mitogen-Activated Protein Kinase 1120174780.130 Why?
Genes, cdc120161140.130 Why?
Tumor Escape120183740.130 Why?
Cyclin-Dependent Kinase 6120183520.130 Why?
Encephalitis120194410.120 Why?
Prognosis62022300280.120 Why?
Recombinant Fusion Proteins1202437350.120 Why?
Chemotherapy, Adjuvant2202335500.120 Why?
Cyclin-Dependent Kinase 4120185640.120 Why?
Epitopes1202125260.110 Why?
Thyroid Diseases120173880.110 Why?
Neoplasm Staging92023112490.110 Why?
Antirheumatic Agents1202313740.110 Why?
Immunotherapy, Adoptive1202415050.110 Why?
Hydroxamic Acids120164820.110 Why?
Herpesvirus 4, Human1201910810.110 Why?
Immunomodulation120175500.110 Why?
Adjuvants, Immunologic320249980.110 Why?
Publishing120208360.110 Why?
Creatinine1201919150.110 Why?
Nevus, Pigmented120152250.110 Why?
Neoplasm Recurrence, Local4202394250.100 Why?
Mental Disorders1201368790.100 Why?
Young Adult112023600450.100 Why?
Radiation Injuries1202012050.100 Why?
Survival Analysis52019101250.100 Why?
Adrenal Cortex Hormones1202118910.100 Why?
Clinical Trials, Phase III as Topic120168760.100 Why?
Lymphoma1202119070.100 Why?
Clinical Trials as Topic2202080510.100 Why?
Histone Deacetylase Inhibitors120167760.090 Why?
Proto-Oncogene Proteins c-kit120157270.090 Why?
Survival Rate32021128750.090 Why?
Neoadjuvant Therapy1202328960.090 Why?
Thromboplastin120122880.090 Why?
Sarcoma1202118060.090 Why?
Israel120137260.090 Why?
Enoxaparin120123910.090 Why?
Leukemia, Lymphocytic, Chronic, B-Cell1202116440.080 Why?
CD4-Positive T-Lymphocytes2201944190.080 Why?
Radiation-Sensitizing Agents120113500.080 Why?
Oximes220233040.080 Why?
Lymphocyte Activation1201954950.080 Why?
Arthritis, Rheumatoid1202337630.080 Why?
Autoimmunity1201613610.070 Why?
Pyrimidinones220233870.070 Why?
Interferons120107140.070 Why?
Neoplasm Proteins1201936110.070 Why?
Deoxycytidine120118880.070 Why?
Vitamin D1202033110.070 Why?
Adolescent72023891680.070 Why?
Thromboembolism1201210060.070 Why?
DNA Mutational Analysis1201441200.060 Why?
Treatment Outcome72017654090.060 Why?
Cell Transformation, Neoplastic1201528470.060 Why?
Inflammatory Bowel Diseases1202024440.060 Why?
Pyridones220238190.060 Why?
Quality of Life22023134970.060 Why?
Gene Expression Profiling1202095070.060 Why?
Follow-Up Studies32021394300.060 Why?
Autoimmune Diseases1201622600.050 Why?
Cohort Studies32022417970.050 Why?
Inflammation12023108650.050 Why?
Colorectal Neoplasms1202369780.050 Why?
Practice Guidelines as Topic1202074510.050 Why?
Leukocytes, Mononuclear2202418550.050 Why?
Adaptation, Psychological1201326650.050 Why?
Dose-Response Relationship, Drug12014107840.050 Why?
Cell Line, Tumor42020171490.050 Why?
Genetic Heterogeneity120247380.050 Why?
New York120238820.050 Why?
T-Lymphocytes12018102730.050 Why?
Disease Progression32023136550.040 Why?
Antigens, CD1201040290.040 Why?
Consensus Development Conferences as Topic120201690.040 Why?
Guanine Nucleotide Exchange Factors120035720.040 Why?
RNA, Double-Stranded120202920.040 Why?
Taxoids120216690.040 Why?
Animals520201694180.040 Why?
HeLa Cells2202030900.040 Why?
Tumor Microenvironment2202139390.040 Why?
Signal Transduction22016236380.040 Why?
Anxiety2202346550.040 Why?
Authorship120202870.040 Why?
Thyrotoxicosis12017850.030 Why?
Anticoagulants1201248400.030 Why?
Mutagenesis, Site-Directed1202016880.030 Why?
Obesity12019130650.030 Why?
Abdominal Pain1202210700.030 Why?
Sentinel Lymph Node Biopsy120207430.030 Why?
Drug Administration Schedule2201648610.030 Why?
Diarrhea1202213200.030 Why?
Necrosis1202016210.030 Why?
Research Personnel120205910.030 Why?
Proportional Hazards Models22021125610.030 Why?
Retreatment120166010.030 Why?
GTP-Binding Protein alpha Subunits, Gq-G11120151480.030 Why?
Cranial Irradiation120173950.030 Why?
Immunologic Factors1202316000.030 Why?
History, 21st Century1202015750.030 Why?
Child32023808630.030 Why?
High-Throughput Nucleotide Sequencing2201736650.030 Why?
Phosphoproteins1200324500.030 Why?
Receptors, Immunologic1202014150.030 Why?
Protein-Tyrosine Kinases1200324340.030 Why?
Drosophila Proteins1200317120.030 Why?
Pancreatic Neoplasms1201154420.030 Why?
Monocytes1202325910.030 Why?
Glucocorticoids1202221700.030 Why?
Histocompatibility Antigens Class II1201714380.030 Why?
Pandemics2202387530.030 Why?
Codon120145990.030 Why?
Vascular Endothelial Growth Factor A1202435200.030 Why?
Hypothyroidism120176700.030 Why?
History, 20th Century1202027720.030 Why?
Lymphocytes1202026110.020 Why?
Ubiquitin Thiolesterase120154670.020 Why?
Melanocytes120155120.020 Why?
Qualitative Research1202331150.020 Why?
CA-19-9 Antigen120111070.020 Why?
Tumor Burden1201719090.020 Why?
Cell-Derived Microparticles120121610.020 Why?
Polymorphism, Single Nucleotide12010160290.020 Why?
Fibrin Fibrinogen Degradation Products120124250.020 Why?
Feasibility Studies1202153080.020 Why?
Consensus1202032070.020 Why?
Imidazoles1201611740.020 Why?
Amino Acid Substitution1201417440.020 Why?
Proteomics1202339010.020 Why?
Pneumonia1202121620.020 Why?
Genomics1202459090.020 Why?
Pilot Projects1202187300.020 Why?
Macrophages1202357970.020 Why?
Risk Assessment22022243110.020 Why?
Neutrophils1202037900.020 Why?
DNA Primers1201028260.020 Why?
Sequence Analysis, DNA1201747800.020 Why?
Amino Acid Sequence12017134520.020 Why?
Tumor Suppressor Proteins1201528190.020 Why?
Sex Factors12019106470.020 Why?
Research Design1202062170.010 Why?
Mice32020820450.010 Why?
Radiotherapy Dosage1201129250.010 Why?
Tomography, X-Ray Computed22017207620.010 Why?
Gene Expression Regulation, Neoplastic1202086350.010 Why?
Patient Selection1201642660.010 Why?
Gene Frequency1201036150.010 Why?
CD8-Positive T-Lymphocytes1201746420.010 Why?
Randomized Controlled Trials as Topic12020103580.010 Why?
Risk Factors22023749150.010 Why?
Focal Adhesion Kinase 1120031200.010 Why?
Focal Adhesion Protein-Tyrosine Kinases120031850.010 Why?
Radiotherapy Planning, Computer-Assisted1201116800.010 Why?
src Homology Domains120033620.010 Why?
Polymerase Chain Reaction1201060910.010 Why?
Body Mass Index12019130300.010 Why?
COS Cells1200311360.010 Why?
Disease Models, Animal12020183880.010 Why?
Mice, Inbred C57BL12018223650.010 Why?
Genotype12014130470.010 Why?
Algorithms12020141580.010 Why?
Base Sequence12010124280.010 Why?
Magnetic Resonance Imaging22017368400.010 Why?
Sensitivity and Specificity12014147280.010 Why?
Mutagenesis1200312300.010 Why?
Sequence Deletion1200314970.010 Why?
Reproducibility of Results12014202310.010 Why?
Prospective Studies12020549140.010 Why?
Drosophila1200315140.010 Why?
Transfection1200357670.010 Why?
Binding Sites1200360300.010 Why?
Time Factors12016402710.010 Why?
Genetic Predisposition to Disease12015180480.010 Why?
Caenorhabditis elegans1200314620.010 Why?
Recombinant Proteins1200365270.010 Why?
Case-Control Studies12010222930.010 Why?
Phosphorylation1200383320.010 Why?
Muscle, Skeletal1200349840.000 Why?
Buchbinder's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (243)
Explore
_
Co-Authors (125)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.